Search - tctmd.com

Displaying 821 - 840 of 951

Sort: Relevancy | Date

News Industry News

Positive Patient Outcomes at One Year With Edwards Sapien XT Transcatheter Valve

May 21, 2013

News Daily News

Patients Who Need Valve-in-Valve After TAVR See Poorer Outcomes

Caitlin E. Cox

May 17, 2013

News Daily News

EVEREST II at 4 Years: Surgery Maintains Early Advantage, But MitraClip Durable

May 17, 2013

News Daily News

EVEREST II a los 4 Años: La Cirugía Mantiene una Ventaja Inicial pero MitraClip es Duradero

May 17, 2013

News Industry News

Direct Flow Medical® Receives IDE Approval for U.S. Salus Trial of Transcatheter Aortic Heart Valve System

May 16, 2013

News Conference News AATS 2013

Promising Early Valve-in-Valve Results Seen in Small Nordic Registry

L.A. McKeown

May 07, 2013

News Daily News

Post-TAVR Hypertension Common, Predicts Better Outcomes

May 03, 2013

News Daily News

La Hipertensión Post-TAVR es Frecuente y Predice Mejores Resultados

May 03, 2013

News Daily News

PARTNER Substudy Looks at Echocardiographic Differences Between TAVR, Surgery

Caitlin E. Cox

April 26, 2013

News Daily News

El Subestudio PARTNER Analiza las Direrencias Ecocardiográficas existentes entre la TAVR y la Cirugía

Caitlin E. Cox

April 26, 2013

News Daily News

Un Meta Análisis Analiza la Regurgitación Post-TAVR y su Influencia sobre la Mortalidad

April 12, 2013

News Daily News

Meta-analysis Looks at Post-TAVR Regurgitation, Influence on Mortality

April 12, 2013

News Daily News

Percutaneous Mitral Commissurotomy Shows Long-term Success, Even with Reintervention

L.A. McKeown

April 05, 2013

News Daily News

La Comisurotomía Mitral Percutánea Revela un Éxito a Largo Plazo, aún con Reintervenciones

L.A. McKeown

April 05, 2013

News Daily News

Close FDA Panel Vote Favors MitraClip for MR Patients with No Other Options

March 25, 2013

News Industry News

FDA Advisory Committee Votes Favorably on Abbott's Minimally Invasive MitraClip® Device for Patients with Significant Mitral Regurgitation Who Are Too High Risk for Surgery

March 20, 2013

News Conference News ACC 2013

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

L.A. McKeown

March 14, 2013

News Conference News ACC 2013

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Yael L. Maxwell

March 11, 2013

News Conference News ACC 2013

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

L.A. McKeown

March 09, 2013

News Industry News

Abbott's Minimally Invasive MitraClip® System for Mitral Regurgitation Demonstrates Positive Clinical and Quality- of-Life Results for Patients Too High Risk for Surgery

March 09, 2013

Advertisement

Positive Patient Outcomes at One Year With Edwards Sapien XT Transcatheter Valve

Patients Who Need Valve-in-Valve After TAVR See Poorer Outcomes

EVEREST II at 4 Years: Surgery Maintains Early Advantage, But MitraClip Durable

EVEREST II a los 4 Años: La Cirugía Mantiene una Ventaja Inicial pero MitraClip es Duradero

Direct Flow Medical® Receives IDE Approval for U.S. Salus Trial of Transcatheter Aortic Heart Valve System

Promising Early Valve-in-Valve Results Seen in Small Nordic Registry

Post-TAVR Hypertension Common, Predicts Better Outcomes

La Hipertensión Post-TAVR es Frecuente y Predice Mejores Resultados

PARTNER Substudy Looks at Echocardiographic Differences Between TAVR, Surgery

El Subestudio PARTNER Analiza las Direrencias Ecocardiográficas existentes entre la TAVR y la Cirugía

Un Meta Análisis Analiza la Regurgitación Post-TAVR y su Influencia sobre la Mortalidad

Meta-analysis Looks at Post-TAVR Regurgitation, Influence on Mortality

Percutaneous Mitral Commissurotomy Shows Long-term Success, Even with Reintervention

La Comisurotomía Mitral Percutánea Revela un Éxito a Largo Plazo, aún con Reintervenciones

Close FDA Panel Vote Favors MitraClip for MR Patients with No Other Options

FDA Advisory Committee Votes Favorably on Abbott's Minimally Invasive MitraClip® Device for Patients with Significant Mitral Regurgitation Who Are Too High Risk for Surgery

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

Abbott's Minimally Invasive MitraClip® System for Mitral Regurgitation Demonstrates Positive Clinical and Quality- of-Life Results for Patients Too High Risk for Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content